Cargando…

PEComa-A Rare Uterine Neoplasm: A Case Report

BACKGROUND: Perivascular Epithelioid Cell Tumors (PEComas) are rare mesenchymal tumors originating from perivascular epithelioid cells. The second common affected organ is uterine. Most of PEComas are benign and patients have good prognosis. At the present time, surgery is the main treatment and adj...

Descripción completa

Detalles Bibliográficos
Autores principales: Padmehr, Roya, Arasteh, Saeid, Aminimoghaddam, Soheila, Rahbari, Ali, Bohloli, Mehrdad, Mir Eskandari, Seyed Mohammad, Mohabbat Dar, Hamid, Ahmad Beigi, Morvarid, Talebi Biderouni, Negin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Avicenna Research Institute 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666591/
https://www.ncbi.nlm.nih.gov/pubmed/36415490
http://dx.doi.org/10.18502/jri.v23i3.10015
_version_ 1784831545775751168
author Padmehr, Roya
Arasteh, Saeid
Aminimoghaddam, Soheila
Rahbari, Ali
Bohloli, Mehrdad
Mir Eskandari, Seyed Mohammad
Mohabbat Dar, Hamid
Ahmad Beigi, Morvarid
Talebi Biderouni, Negin
author_facet Padmehr, Roya
Arasteh, Saeid
Aminimoghaddam, Soheila
Rahbari, Ali
Bohloli, Mehrdad
Mir Eskandari, Seyed Mohammad
Mohabbat Dar, Hamid
Ahmad Beigi, Morvarid
Talebi Biderouni, Negin
author_sort Padmehr, Roya
collection PubMed
description BACKGROUND: Perivascular Epithelioid Cell Tumors (PEComas) are rare mesenchymal tumors originating from perivascular epithelioid cells. The second common affected organ is uterine. Most of PEComas are benign and patients have good prognosis. At the present time, surgery is the main treatment and adjuvant chemotherapy is used in malignant cases, although the best diagnostic and management method is yet to be discovered considering the rarity of this neoplasm. CASE PRESENTATION: The patient was a 53 year old lady with a history of two vaginal deliveries and no previous surgery. She had severe pelvic pain and underwent MRI with the primary impression of sarcoma. In MRI, she had a 7 cm mass in lower segment of uterus. The patient underwent laparoscopic hysterectomy, bilateral oophorectomy, lymphadenectomy, and omental biopsy in Jam Hospital. Pathologic report of the patient revealed malignant PEComa without lymph node and omentum involvement. CONCLUSION: Diagnosis of PEComa before surgery is difficult and its differential diagnoses form uterine leiomyoma or leiomyosarcoma. Final diagnosis can be made after surgical biopsy and immunohistochemistry evaluation. Surgery is still the main treatment and adjuvant therapy is used in high risk patients.
format Online
Article
Text
id pubmed-9666591
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Avicenna Research Institute
record_format MEDLINE/PubMed
spelling pubmed-96665912022-11-21 PEComa-A Rare Uterine Neoplasm: A Case Report Padmehr, Roya Arasteh, Saeid Aminimoghaddam, Soheila Rahbari, Ali Bohloli, Mehrdad Mir Eskandari, Seyed Mohammad Mohabbat Dar, Hamid Ahmad Beigi, Morvarid Talebi Biderouni, Negin J Reprod Infertil Case Report BACKGROUND: Perivascular Epithelioid Cell Tumors (PEComas) are rare mesenchymal tumors originating from perivascular epithelioid cells. The second common affected organ is uterine. Most of PEComas are benign and patients have good prognosis. At the present time, surgery is the main treatment and adjuvant chemotherapy is used in malignant cases, although the best diagnostic and management method is yet to be discovered considering the rarity of this neoplasm. CASE PRESENTATION: The patient was a 53 year old lady with a history of two vaginal deliveries and no previous surgery. She had severe pelvic pain and underwent MRI with the primary impression of sarcoma. In MRI, she had a 7 cm mass in lower segment of uterus. The patient underwent laparoscopic hysterectomy, bilateral oophorectomy, lymphadenectomy, and omental biopsy in Jam Hospital. Pathologic report of the patient revealed malignant PEComa without lymph node and omentum involvement. CONCLUSION: Diagnosis of PEComa before surgery is difficult and its differential diagnoses form uterine leiomyoma or leiomyosarcoma. Final diagnosis can be made after surgical biopsy and immunohistochemistry evaluation. Surgery is still the main treatment and adjuvant therapy is used in high risk patients. Avicenna Research Institute 2022 /pmc/articles/PMC9666591/ /pubmed/36415490 http://dx.doi.org/10.18502/jri.v23i3.10015 Text en Copyright© 2022, Avicenna Research Institute. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Case Report
Padmehr, Roya
Arasteh, Saeid
Aminimoghaddam, Soheila
Rahbari, Ali
Bohloli, Mehrdad
Mir Eskandari, Seyed Mohammad
Mohabbat Dar, Hamid
Ahmad Beigi, Morvarid
Talebi Biderouni, Negin
PEComa-A Rare Uterine Neoplasm: A Case Report
title PEComa-A Rare Uterine Neoplasm: A Case Report
title_full PEComa-A Rare Uterine Neoplasm: A Case Report
title_fullStr PEComa-A Rare Uterine Neoplasm: A Case Report
title_full_unstemmed PEComa-A Rare Uterine Neoplasm: A Case Report
title_short PEComa-A Rare Uterine Neoplasm: A Case Report
title_sort pecoma-a rare uterine neoplasm: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666591/
https://www.ncbi.nlm.nih.gov/pubmed/36415490
http://dx.doi.org/10.18502/jri.v23i3.10015
work_keys_str_mv AT padmehrroya pecomaarareuterineneoplasmacasereport
AT arastehsaeid pecomaarareuterineneoplasmacasereport
AT aminimoghaddamsoheila pecomaarareuterineneoplasmacasereport
AT rahbariali pecomaarareuterineneoplasmacasereport
AT bohlolimehrdad pecomaarareuterineneoplasmacasereport
AT mireskandariseyedmohammad pecomaarareuterineneoplasmacasereport
AT mohabbatdarhamid pecomaarareuterineneoplasmacasereport
AT ahmadbeigimorvarid pecomaarareuterineneoplasmacasereport
AT talebibiderouninegin pecomaarareuterineneoplasmacasereport